Tigo Energy Solar Safety Technology Protects Belectric-Installed 19 MW Floating Solar System
7.8.2023 16:00:00 EEST | Business Wire | Press release
Tigo Energy, Inc. (Nasdaq: TYGO), a leading provider of intelligent solar and energy storage solutions, today announced that Belectric Israel Ltd, a premier solar engineering, installation, and service provider in Israel, has deployed Tigo technology on one of the largest floating PV (FPV) systems in the region.
Designed, purchased, and constructed by Belectric, the 19.3 MW FPV was outfitted with Tigo Energy TS4-A-2F MLPE devices for rapid shutdown, as well as Tigo RSS Transmitters with Pure Signal™ for large and complex commercial and industrial solar systems. The system is constructed over an active fish farm, producing enough energy to power approximately 3,300 houses.
"The components were relatively simple to integrate into our design and plans for execution, and the quality of the service gave us the confidence we needed to ensure that our operations and maintenance teams can do their work safely”, said Anna Velikansky, chief executive officer at Belectric Israel Ltd.
Built on patented advanced rapid shutdown technology, Tigo RSS Transmitters with Pure Signal technology pair with an industry-leading list of third-party solar inverters, deliver a new level of design and installation flexibility for solar installers and EPCs (Engineering, Procurement, and Construction companies), and enable significant reductions in the balance of system (BOS) and labor costs.
“The continued growth of solar energy in Israel and globally requires comprehensive and flexible systems that installers can deploy with confidence and ease, even when those systems float on top of agricultural reservoirs,” said Gal Bauer, senior director of validation and general manager at Tigo Energy in Israel. “We are delighted to collaborate with companies like Belectric that maximize the benefits of Tigo technology to serve their customers. The success of this FPV system demonstrates once again what is possible for solar, and we look forward to continuing to support Belectric as a leader in the commercial and utility solar space.”
Tigo RSS Transmitters with Pure Signal technology are UL PVRSS certified with hundreds of inverter models from leading manufacturers. The new generation of RSS Transmitters with Pure Signal technology is compatible with the company’s TS4-A-F and TS4-A-2F rapid shutdown product family and can be easily integrated into new projects or retrofitted into existing installations. Tigo systems are backed by the Tigo Energy Intelligence (EI) platform, a comprehensive digital platform designed to optimize solar installations' planning, installation, commissioning, monitoring, and maintenance phases, from individual residential systems to commercial, industrial, and utility-scale solar fleets. Tigo EI delivers the tools to decrease operations and maintenance costs, increase system performance and revenue, and improve the user experience for installers and asset owners.
For more information about the Tigo TS4 product line, please visit our website.
About Tigo Energy
Founded in 2007, Tigo is a worldwide leader in the development and manufacture of smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Tigo combines its Flex MLPE (Module Level Power Electronics) and solar optimizer technology with intelligent, cloud-based software capabilities for advanced energy monitoring and control. Tigo MLPE products maximize performance, enable real-time energy monitoring, and provide code-required rapid shutdown at the module level. The company also develops and manufactures products such as inverters and battery storage systems for the residential solar-plus-storage market. For more information, please visit www.tigoenergy.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230807277660/en/
Contact information
Tigo Israel Media Contact:
Liel Edry (KAMIR)
+972-50-8655-305
liel@kamir-e.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 02:51:00 EEST | Press release
Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equity among HCPs, patients, regulators and other stakeholders. A global leader in women’s health, the company’s portfolio includes more than 70 products across Women’s Health and General Medicines, which includes biosimila
PMC Organometallix Announces Price Increase on All Products25.4.2026 00:02:00 EEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health24.4.2026 19:52:00 EEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 17:37:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be entitled to benefits including enhanced communications and a shortened 1-2 month review time following filing of a New Drug Application (NDA), while maintaining FDA’s rigorous safety and efficacy standards. “We are honored and grateful to be selected for the CNPV which is a clear validation of both the urgent unmet need facing millions of people living with treatment resistant depression and the innovative science of COMP360,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “As the most advan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom